Dusky erythema secondary to anti-MEK therapy

Melanoma Res. 2019 Aug;29(4):449-451. doi: 10.1097/CMR.0000000000000602.

Authors

Bernardo Bancalari¹, María A Algarra², Beatriz Llombart¹, Eduardo Nagore¹, Virtudes Soriano², Onofre Sanmartín¹, Celia Requena¹

Affiliations

¹ Departments of Dermatology.
² Oncology, Valencian Oncology Institute, Valencia, Spain.

PMID: 31246729
DOI: 10.1097/CMR.0000000000000602

No abstract available

MeSH terms

Erythema / chemically induced*
Humans
Mitogen-Activated Protein Kinase Kinases / adverse effects*
Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors*
Molecular Targeted Therapy / adverse effects*

Substances

Mitogen-Activated Protein Kinase Kinases